Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44551 - 44575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Furazolidone	Investigational Vet Approved	CDK6	1021	upregulated	Furazolidone results in increased expression of CDK6 mRNA	7q21.2	A22738 A22739
Furazolidone	Investigational Vet Approved	CDKN1A	1026	upregulated	Furazolidone results in increased expression of CDKN1A mRNA	6p21.2	A22740
Furosemide	Approved Investigational Vet Approved	UGT1A1	54658	upregulated	Furosemide results in increased expression of UGT1A1 mRNA	2q37.1	A21482
Gadodiamide	Approved Investigational	ALDH1A1	216	upregulated	gadodiamide results in increased expression of ALDH1A1 mRNA	9q21.13	A22741
Gadodiamide	Approved Investigational	ANKRD22	118932	upregulated	gadodiamide results in increased expression of ANKRD22 mRNA	10q23.31	A22741
Gadodiamide	Approved Investigational	APOBEC3A	200315	upregulated	gadodiamide results in increased expression of APOBEC3A mRNA	22q13.1	A22741
Gadodiamide	Approved Investigational	ATM	472	upregulated	gadodiamide results in increased expression of ATM mRNA	11q22.3	A22741
Gadodiamide	Approved Investigational	ATP8B1	5205	upregulated	gadodiamide results in increased expression of ATP8B1 mRNA	18q21.31	A22741
Gadodiamide	Approved Investigational	CCL2	6347	upregulated	gadodiamide results in increased expression of CCL2 mRNA	17q12	A22741
Gadodiamide	Approved Investigational	CCL8	6355	upregulated	gadodiamide results in increased expression of CCL8 mRNA	17q12	A22741
Gadodiamide	Approved Investigational	CD1C	911	upregulated	gadodiamide results in increased expression of CD1C mRNA	1q23.1	A22741
Gadodiamide	Approved Investigational	CXCL10	3627	upregulated	gadodiamide results in increased expression of CXCL10 mRNA	4q21.1	A22741
Gadodiamide	Approved Investigational	CXCL11	6373	upregulated	gadodiamide results in increased expression of CXCL11 mRNA	4q21.1	A22741
Gadodiamide	Approved Investigational	CXCL12	6387	upregulated	gadodiamide results in increased expression of CXCL12 mRNA	10q11.21	A22741
Gadodiamide	Approved Investigational	CXCL9	4283	upregulated	gadodiamide results in increased expression of CXCL9 mRNA	4q21.1	A22741
Gadodiamide	Approved Investigational	IDO1	3620	upregulated	gadodiamide results in increased expression of IDO1 mRNA	8p11.21	A22741
Gadodiamide	Approved Investigational	IFI44L	10964	upregulated	gadodiamide results in increased expression of IFI44L mRNA	1p31.1	A22741
Gadodiamide	Approved Investigational	IFIT1	3434	upregulated	gadodiamide results in increased expression of IFIT1 mRNA	10q23.31	A22741
Gadodiamide	Approved Investigational	IFIT3	3437	upregulated	gadodiamide results in increased expression of IFIT3 mRNA	10q23.31	A22741
Gadodiamide	Approved Investigational	IFNG	3458	upregulated	gadodiamide results in increased expression of IFNG mRNA	12q15	A22742
Gadodiamide	Approved Investigational	IL13	3596	upregulated	gadodiamide results in increased expression of IL13 mRNA	5q31.1	A22742
Gadodiamide	Approved Investigational	IL4I1	259307	upregulated	gadodiamide results in increased expression of IL4I1 mRNA	19q13.33	A22741
Gadodiamide	Approved Investigational	IL6	3569	upregulated	gadodiamide results in increased expression of IL6 mRNA	7p15.3	A22742
Gadodiamide	Approved Investigational	MMP1	4312	upregulated	gadodiamide results in increased expression of MMP1 mRNA	11q22.2	A22743
Gadodiamide	Approved Investigational	NXPE3	91775	upregulated	gadodiamide results in increased expression of NXPE3 mRNA	3q12.3	A22741

Displaying entries 44551 - 44575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability